Development And Content Validity Testing Of A Treatment Acceptance Measure For Use In Hypercholesterolemia Patients Receiving Treatment Via Subcutaneous Injection
Value Health
.
2014 Nov;17(7):A569.
doi: 10.1016/j.jval.2014.08.1898.
Epub 2014 Oct 26.
Authors
S Tatlock
1
,
L Grant
1
,
R Arbuckle
1
,
I Khan
2
,
G Manvelian
3
,
R Sanchez
3
Affiliations
1
Adelphi Values Ltd, Bollington, UK.
2
Sanofi, Bridgewater, NJ, USA.
3
Regeneron Pharmaceuticals, Tarrytown, NY, USA.
PMID:
27201898
DOI:
10.1016/j.jval.2014.08.1898
No abstract available